Summarized by Masters of Longevity from Frontiers - Health.
PAX1 promoter methylation was independently associated with histologic HSIL+ after Aptima HPV testing.

Key Takeaways
- PAX1 methylation was associated with higher HSIL+ odds.
- Adding PAX1 modestly improved AUC versus clinical baseline model.
- The single-center observational design means causality remains unproven.



